This month, the Central Drugs Standard Control Organization (CDSCO) has approved Ranibizumab for the treatment of: Neovascular (Wet) Age-Related Macular Degeneration (AMD) Visual Impairment Due to Diabetic Macular Oedema (DME) As diabetes and age-related eye diseases continue to rise, innovations that help preserve vision are becoming more critical than ever
Glutathione production naturally declines as a person ages and bodily stores are depleted when one is stressed, lack sleep, or have suffered prolonged illnesses
Its GLP-1 program pairs FDA-approved treatments like Wegovy and Ozempic with coaching and nutrition advice
CEOs, VPs of R&D, regulatory affairs leaders, and commercial directors from biotechnology firms, CDMOs, and GLP-1 drug manufacturers comprised the supply-side sources
Beyond its role in fat metabolism, L-Carnitine also supports muscle function and helps regulate glucose metabolism, making it an essential nutrient for overall energy and metabolic health
Conover and Andersen project that the global market for obesity drugs will be $120 billion by 2031 and most of the market will be relatively split between Novo and Lilly